Chaim Frenkel

Title: Chaim Frenkel: Innovator in Plant Cell Culture

Introduction

Chaim Frenkel is a notable inventor based in North Brunswick, NJ, who has made significant contributions to the field of plant cell culture. With a total of two patents to his name, Frenkel's work focuses on enhancing the production of metabolites in plant cells through innovative methods.

Latest Patents

Frenkel's latest patents include a method of using an elicitor to increase the production of metabolites in plant cells. This method involves culturing fungal and plant cells in a medium containing an elicitor, which significantly boosts the production of metabolites such as nicotine in tobacco leaves. The elicitor can be oxidized Bovine Serum Albumin (BSA), glycosylated BSA, oxidized lysozyme, glycosylated lysozyme, or azetidine-2-carboxylic acid. Notably, the production of metabolites can increase by up to 1000% when an elicitor is added during the culturing process. Another patent focuses on stimulating cell multiplication, differentiation, or somatic embryogenesis of higher plant cells in tissue culture by adding an effective amount of extensin preparation derived from higher plant tissue.

Career Highlights

Throughout his career, Chaim Frenkel has worked with prestigious institutions such as Rutgers, the State University of New Jersey, and Bar-Ilan University. His research has contributed to advancements in plant biotechnology and has opened new avenues for agricultural innovation.

Collaborations

Frenkel has collaborated with notable colleagues, including Bezalel Kessler and Daphna Frenkel, which has further enriched his research endeavors and expanded the impact of his inventions.

Conclusion

Chaim Frenkel's innovative approaches to plant cell culture and metabolite production demonstrate his commitment to advancing agricultural science. His patents reflect a deep understanding of plant biology and a drive to enhance productivity in the field.